INTRODUCTION
Sheep are the natural hosts of scrapie, the first transmissible spongiform encephalopathy (TSE) to be described, and are also susceptible to experimental infection by other TSE agents, such as those causing transmissible mink encephalopathy (Hadlow et al., 1987) and bovine spongiform encephalopathy (BSE) (Foster et al., 1993) . The susceptibility of sheep to BSE, together with the widely accepted theory of BSE being the origin of variant Creutzfeldt-Jakob disease (vCJD; Collinge et al., 1996; Bruce et al., 1997; Hill et al., 1997; Scott et al., 1999) , have raised considerable concern. In Great Britain in particular, the size of the BSE epidemic and management practices suggest that sheep could have been exposed to natural infection through contaminated feedstuffs (Schreuder & Somerville, 2003) . Moreover, in experimental ovine BSE, disease-associated prion protein (PrP d ) and infectivity are widespread throughout tissues of the lymphoreticular system (LRS), the gastrointestinal tract (Foster et al., 2001; Jeffrey et al., 2001b) and blood Hunter et al., 2002) . In this respect, sheep BSE resembles sheep scrapie more closely than cattle BSE and, thus, the possibility exists that it could be transmitted between infected and uninfected sheep and maintained even in the absence of the original source of infection. Whether natural BSE in sheep is merely a hypothetical possibility is open to debate (Schreuder & Somerville, 2003) but, in any case, the search for methods that may allow differentiation between scrapie and BSE in sheep is a current priority.
The classical method of TSE strain typing involves transmission and serial passage of infectious material ('isolate') in a panel of inbred mouse lines and its characterization by the incubation period of the disease in mice and the vacuolar lesion profile in brain (Fraser & Dickinson, 1973) . This method has allowed discrimination between BSE and several sheep scrapie strains, leading to the conclusion that the BSE agent is a unique, single strain that is stable after passage in different species, including sheep (Bruce et al., 1994 (Bruce et al., , 1997 Foster et al., 1996) .
Either after passage in mice or directly in original tissues, assessment of the biochemical profile of TSE isolates by immunoblotting (glycotyping) attempts the characterization of TSE strains by differences in the proportions of the three glycoforms of protease-resistant PrP (PrP res ) and in the molecular mass (MM) of the aglycosyl moiety after protease digestion. Despite some variability in the results of the studies carried out so far (reviewed by Schreuder & Somerville, 2003) , the general pattern is that the aglycosyl fraction runs more slowly (higher MM) in most scrapie sources tested than in experimental ovine BSE (lower MM). This probably reflects differences in the cleavage site within the N terminus of abnormal PrP, a notion that is confirmed by the absence or marked reduction of the bands when sheep BSE gels are incubated with mAb P4 (Stack et al., 2002) , which recognizes the 93-99 PrP epitope (Thuring et al., 2004) . However, immunoblot patterns similar to those of sheep BSE have been described for CH1641, a classical experimental scrapie source (Hope et al., 1999) , and the biochemical properties of PrP res may depend not just on the TSE agent, but also on the tissue type and even area within the brain (Somerville, 1999) .
The concept of differential truncation of the N terminus of sheep BSE-derived PrP was first proposed by Jeffrey et al. (2001a) , who used immunohistochemistry (IHC) with a panel of PrP antibodies to distinguish between experimental ovine BSE and several sheep scrapie sources. Further studies indicated that, unlike scrapie, the site of truncation within the flexible tail of ovine BSE PrP d was tissue-and even celltype-dependent and that differentiation between the two infections could be approached by examining neural and non-neural tissues, particularly those of the LRS. Whilst the initial studies were restricted to sheep of the ARQ/ARQ PrP genotype, recent extended examinations have pointed out that the pattern of immunolabelling is identical in experimental BSE of sheep of other genotypes (Martin et al., 2005) . We have previously reported the possible usefulness of the 'PrP d profile' for characterization of scrapie strains (González et al., 2002) . Unlike the 'lesion profile', which addresses the magnitude of neuropil vacuolation in specific brain areas, the method is based on IHC recognition and scoring of different morphological and cell-associated types and patterns of PrP d accumulation in the brains of affected sheep. The PrP d profile appears to be mainly determined by the TSE agent or strain, with other factors, particularly the PrP genotype, producing only minor effects (González et al., 2003a) . It has been hypothesized that these distinct profiles can reflect differences in cellular tropism and in PrP processing by different TSE strains (González et al., 2003b) . In the present study, we have used a similar IHC-profiling method to characterize the phenotype of PrP d accumulation in the brains of sheep affected experimentally with BSE, and have assessed the effects of several factors. Our intention was to provide further tools for discriminating between scrapie and ovine BSE and to contribute to the understanding of the pathogenesis of sheep TSEs.
METHODS
Animals and experimental procedures. IHC examination for PrP d accumulation was performed in the brains of 64 sheep, all of which showed neurological signs after experimental infection with the BSE agent. These animals were gathered from several ongoing and completed experiments and were grouped according to breed and PrP genotype, source and type of inoculum and route of challenge, as detailed in Table 1. Sheep were of four different breeds [Cheviot (n=27), Poll-Dorset (n=7), Suffolk (n=12) and Romney (n=18)] and five different PrP genotypes [ARQ/ARQ (n=42), ARQ/AHQ (n=6), AHQ/AHQ (n=3), VRQ/VRQ (n=5) and ARR/ARR (n=8)], which are indicated as polymorphisms at codons 136, 154 and 171 for the two alleles (the single-letter amino acid code is used). PrP genotyping was performed by sequencing of PCR-amplified products (Baylis et al., 2000) . The animals had been exposed experimentally to BSE infection by one of three routes [intracerebral (IC, n=40), intravenous (IV, n=11) or oral (n=13)], using either blood (n=5) or brain homogenates (n=59) from either of two host sources [cattle (n=40) or sheep (n=24)]. Details of experimental procedures have been given elsewhere [for IC challenge by Foster et al. (1993) , for oral challenge by Jeffrey et al. (2001b) and for IV challenge by Hunter et al. (2002) ] and were also summarized by Martin et al. (2005) . The protocol for inoculation of sheep-passaged BSE inoculum was identical to that described for cattle inoculum.
All sheep were monitored closely and were killed humanely once clinical signs were considered to be highly suggestive of TSE (Table 1) . The clinical period extended from 1 to 10 days in approximately 50 % of the sheep, from 11 to 30 days in another 25 % and from 1 to 5 months in the remaining sheep. Three of the eight ARR/ARR sheep succumbing to BSE IC challenge were those reported by Houston et al. (2003) and the other five belonged to the same experimental series.
IHC examinations and PrP d profile. Brains were fixed in formaldehyde, trimmed and embedded in paraffin wax according to standard procedures. A detailed account of the IHC protocol, including antigen retrieval and blocking steps, was given previously (González et al., 2002) . Primary antibody R486 was used in 21 animals and PrP antibody R145 in the remaining 43; ten sheep were examined with both antibodies to ensure comparability of results. R486 and R145 are, respectively, a rabbit anti-PrP polyclonal antiserum and a rat mAb that recognize bovine PrP amino acid residues 217-231 (R. Jackman, personal communication). Sections from positivecontrol tissue blocks were included in each IHC run to ensure consistency in the sensitivity of the method. Apart from internal negative controls of the IHC technique (substitution of primary antibody by normal rabbit serum or normal rat IgG), each run also included negative-control tissues from TSE-unexposed sheep.
Brains were examined at six different neuroanatomical sites: frontal cerebral cortex, corpus striatum, thalamus/hypothalamus, midbrain, cerebellum at the vermis and medulla oblongata at the obex. Most of the PrP d types and patterns considered at these sites corresponded to those already described in previous publications (González et al., 2002 (González et al., , 2003b (Jeffrey et al., 1990 (Jeffrey et al., , 1994 and sheep (M. Jeffrey and others, unpublished observations). Other PrP d types that were sought were those related to blood vessels (vascular plaques), ependymal and choroid plexus cells and oligodendrocytes.
Construction of the PrP d profiles has been described in detail previously (González et al., 2002) . The magnitude of accumulation of the above PrP d types was scored from 0 to 3 (Fig. 1 
RESULTS
Negative-control brain samples and normal serum-treated tissue sections produced no immunoreactivity, whereas positive-control sections gave specific immunolabelling of comparable intensity in all IHC runs performed.
Topographical description of the PrP d profile
None of the animals investigated showed PrP d accumulation in the choroid plexus or in the form of vascular plaques. Detection of PrP d associated with oligodendrocytes was attempted in the corpus callosum and in the cerebellar white matter; although some immunolabelling was observed at these points, it was unclear whether it was associated with oligodendrocytes or with intermingled astrocytes. Therefore, no separate quantification of oligodendroglial PrP d was performed. Subependymal and ependymal PrP d deposits were generally mild and inconsistent and, except for a few IC-challenged sheep in which lateral ventricles were involved, they were restricted to the third ventricle.
Cerebral cortex. The magnitude of PrP d accumulation in the cerebral cortex was in general lower than in other areas. The predominant types were the subpial and stellate in the grey matter and the perivacuolar in the white matter. The latter tended to appear at the margins of the gyral white-matter tips, subjacent to the grey-matter junction (Fig. 2a) , and was often associated with perivascular PrP d accumulations that seemed to be made of coalescing perivacuolar deposits (Fig. 2b) . Intra-astrocytic, intraneuronal and intramicroglial PrP d accumulation in the grey matter was of low grade and inconsistent.
Corpus striatum. The pattern of PrP d accumulation at this site was characteristic (Fig. 2c, d ). Intraneuronal deposits were moderate in the caudate nucleus and more prominent in the globus pallidus and putamen nuclei and, in many instances, PrP d accumulated in neurons that also showed perineuronal deposits. The main type of neuropil accumulation of PrP d was in the form of thick linear threads, which often connected with the perineuronal aggregates (Fig. 2e) . Intramicroglial PrP d accumulation was consistent and prominent, with affected cells appearing scattered in the neuropil and occasionally also within intraneuronal vacuoles (Fig. 2f) . Extracellular PrP d of the stellate type was conspicuous (Fig. 2c, d ), whilst the presence of intra-astrocytic, perivacuolar and perivascular PrP d was negligible. Because of the lack of the latter two types, the white-matter bundles of the external and internal capsules were characteristically devoid of PrP d (Fig. 2d) . (Fig. 2g) .
Midbrain. The overall magnitude of PrP d accumulation was greatest at this site. The predominant intracellular types were the intraneuronal, particularly in the red nucleus, and the intramicroglial. The intra-astrocytic type, in contrast, was seldom found and only in low amounts. Marked and consistent PrP d deposits were found in the neuropil, particularly in the substantia nigra, where the linear and the particulate/coalescing types were characteristic (Fig. 2h) (Fig. 2i) . Multigranular deposits of PrP d in the cytoplasm of astrocyte-like cells were evident in the whitematter tips of most sheep (Fig. 2j) . , 10 24 and 10 25 dilutions were 520±19?4, 554±35?0 and 756±48?0 days, respectively (two sheep out of five of the latter group were still alive at 1550 days post-infection). In spite of these differences, the PrP d phenotypes of the three subgroups were almost identical (results not shown). The absence of correlation between PrP d phenotype and incubation period extended to all sheep groups studied (see next section). The magnitude of total PrP d was also unrelated to the duration of the clinical disease, the incubation period or the age at challenge (Table 1 ).
Medulla oblongata (obex
The breed of sheep did not affect either the magnitude of total PrP d accumulation (Table 1 ; compare groups 1, 2 and 3), its profile (Fig. 3a) or its topographical distribution (data not shown). The host source of inoculum (cattle or sheep) did not influence the PrP d profile, but appeared to have a slight contradictory effect on the magnitude of total PrP d (Fig. 3b, c) . Thus, whilst sheep challenged IC with infected cattle brain accumulated slightly more PrP d than those of the same genotype infected with sheep BSE inoculum (Table 1 ; compare groups 1-3 with group 4), the opposite was observed with animals challenged orally (groups 8 and 9). For these comparisons, sheep of different breeds were grouped, but, as described above and in comparisons made within group 9 (data not shown), the breed did not seem to have an effect on the PrP daccumulation phenotype.
An unambiguous effect of the PrP genotype was found when ARR/ARR sheep were compared with other groups, but no differences were observed between ARQ/ARQ and VRQ/VRQ sheep (Fig. 4a) (Fig. 4b) , although miniature pseudoplaques in the neuropil, often arranged in rows, were most conspicuous and widespread in ARR/ARR sheep.
The route of inoculation influenced the magnitude of total PrP d accumulation and, to a lesser extent, the PrP d profile (Fig. 5a, b) . Sheep challenged by the IC route accumulated almost 50 % more PrP d than those dosed orally and more than twice than animals inoculated IV (Table 1) . Within the IV group, however, ARQ/ARQ animals receiving sheep to those challenged by other routes in and caudal to the midbrain, the differences being particularly noticeable in the cerebral cortex (Fig. 5c ). This was reflected in the PrP d profile, so that orally and IV-infected sheep showed lower levels of the PrP d types found commonly in the forebrain (subpial, stellate, perivacuolar and perivascular) than did IC-challenged sheep (Fig. 5a, b) .
Effect of PrP genotype and route of infection on incubation period and magnitude of total PrP d accumulation
Sheep of the ARQ/ARQ genotype and those carrying the AHQ allele had significantly shorter incubation periods than ARR/ARR and VRQ/VRQ allele-bearing animals (Fig. 6 ). Amongst the ARQ/ARQ animals, those challenged IC and IV had shorter incubation periods than sheep dosed orally, among which one sheep showed a very protracted infection (1132 days). Conversely, AHQ homozygotes challenged orally had a shorter incubation period than ARQ/AHQ sheep inoculated IV with cattle brain. The incubation period, however, was not the factor determining the magnitude of total PrP d accumulation in the brain, as ARR sheep showed much lower levels of PrP d than did VRQ animals. Also, AHQ sheep showed a lower magnitude of PrP d accumulation than ARQ homozygotes, a difference that was clear when groups challenged by the same route were compared (Fig. 6) . 
DISCUSSION
After passage in inbred mice, the 'BSE signature' can be recognized by incubation period, vacuolar lesion profile (Fraser et al., 1992; Bruce et al., 1994) and glycotyping (Collinge et al., 1996; Hill et al., 1997) . This signature is the same regardless of the source of the original isolate, i.e. cattle, sheep or other species, including humans (Bruce et al., 1997; Hill et al., 1997) . With this study, we show that, by detailed IHC examination, a similar signature can be identified in BSE-infected sheep irrespective of breed, PrP genotype, route of inoculation or source, type and dose of inoculum.
PrP d phenotype of BSE in sheep
In spite of differences in overall magnitude and, to a lesser extent, topographical distribution of PrP d deposition in the brain, the PrP d profile was remarkably similar in all BSEinfected sheep examined. In our series, PrP d accumulated at the highest levels in the brainstem, thalamus/hypothalamus and cerebellum, and at the lowest levels in the cerebral cortex. After IC challenge, however, PrP d deposits in the cerebral cortex and particularly in the striatum were conspicuous (presumably reflecting its proximity to the injection point), whereas aggregates in the cerebellum were mild following IV infection (Fig. 5c) . As a result, the magnitude of total PrP d deposition in the brain was highest in IC-challenged sheep and lowest in IV-inoculated animals. Another factor, the PrP genotype, also influenced the overall amount of PrP d in the brain, its effect being evident in ARR homozygotes, which showed low PrP d levels. Similarly, ARQ/AHQ sheep accumulated little PrP d , but, in this case, a combined effect of the route of challenge (IV) and the source and type of inoculum (cattle brain) could not be analysed separately. (González et al., 2002 (González et al., , 2003b  Fig. 7 ). It was also very different from that generated by infection of sheep with the CH1641 scrapie strain ( Fig. 7 ; M. Jeffrey & L. González, unpublished observations), a finding of particular relevance in view of the reported biochemical similarities between both agents (Hope et al., 1999; Stack et al., 2002) . Furthermore, the features of sheep BSE reported here are indistinguishable from those described following infection of Lacaune sheep with a French isolate of cattle BSE (Lezmi et al., 2004) , but very different from atypical scrapie cases, such as the recently reported Nor98 type (Benestad et al., 2003; M. Jeffrey & L. González, unpublished 
observations).
Our results suggest that a systematic IHC assessment of PrP d accumulation in the brain would be suitable for identification of naturally occurring BSE in sheep. This is supported by several findings: firstly, the consistency of the profile across sheep breeds (see Fig. 3a ) and, allowing for magnitude differences, PrP genotypes (Fig. 4a, b) ; secondly, the absence of effect of the host source of the inoculum on the PrP d profile (Fig. 3b, c) , which agrees with the stability of cross-species-passaged BSE found in mice (Bruce et al., 1994) and with the similarity of glycoprofiles and IHClabelling properties between cattle-derived and sheeppassaged ovine BSE (M. Stack and others, unpublished observations) in the brain points towards a 'BSE signature' in sheep that would persist after a potential recirculation of BSE in sheep following the removal of the original source of infection.
PrP d phenotype of BSE in other species
The consistency of the BSE phenotype in sheep does not parallel the variation detected when different species are compared. Thus, the abundance of PrP d plaques in mice carrying the p7 Sinc allele (Fraser et al., 1992; Brown et al., 2003) , in experimentally infected macaque monkeys (Lasmézas et al., 1996) and in vCJD patients contrasts with the almost-complete absence of amyloid/PrP plaques in other species. In addition to sheep, as reported above, neither pigs (Ryder et al., 2000) , cats (Wyatt et al., 1991) nor exotic ungulates (Jeffrey & Wells, 1988) develop such plaques, and they are absent or very rare in BSE cases affecting British cattle (Wells & McGill, 1992; Wells & Wilesmith, 1995) . Assessing similarities or differences for PrP d types other than plaques proves difficult, due to lack of detailed descriptions of the PrP d -accumulation patterns in other species. From the literature, however, accumulation of PrP d in cattle BSE targets grey matter rather than white matter and includes granular or particulate, linear and perineuronal types in the neuropil, as well as intraneuronal and stellate types (Wells & Wilesmith, 1995) . These descriptions are coincident with our observations on sheep BSE, as are the findings of intraneuronal, neuropil-associated and stellate PrP d accumulations in the brainstem and corpus striatum of experimentally infected pigs (Ryder et al., 2000) . (Fraser et al., 1992; Brown et al., 2003) . With the exception of the miniature pseudoplaques, which were found almost exclusively in ARR/ARR sheep, we have not observed similar qualitative effects of the PrP genotype in sheep, but rather one on the magnitude of PrP d accumulation. This effect was unambiguous in ARR/ARR sheep and probably also in those carrying the AHQ allele. In our study, the host PrP genotype also appeared to influence the incubation period, which was very lengthy for ARR and VRQ homozygotes and VRQ allele-bearing sheep (Table 1 ; Fig. 6 ). In contrast, ARQ homozygotes had much shorter incubation periods, although this was apparently modulated by the route of challenge. The two groups of sheep carrying the AHQ allele also had short incubation periods, but the route of infection appeared to have an opposite effect; this, however, could also reflect genotype differences (homo-and heterozygotes) or result from interaction between source and type of inoculum (cattle brain) and route of challenge. (Bossers et al., 1997 (Bossers et al., , 2000 . These findings might explain our observations in ARQ/ARQ and ARR/ARR sheep, but not the inverse relationship between incubation period and PrP d levels found in VRQ and AHQ sheep. We hypothesize that conversion/accumulation of VRQ PrP is efficient, hence the high PrP d levels found in these sheep, but starts late after infection, hence the long incubation period, and that just the opposite situation (low efficiency but early start) could happen in AHQ sheep.
Another intriguing question, derived from the low PrP d levels found in ARR and AHQ sheep, regards the significance of PrP d to clinical disease, as it seems clear from the evidence shown that they are not proportionally related. This finding is not unique to sheep BSE and has also been described when comparing SSBP/1 with natural scrapie (González et al., 2002 
